Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bernard, P.
Right arrow Articles by Vilain, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernard, P.
Right arrow Articles by Vilain, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2003, Vol. 12, No. 14 1755-1765
DOI: 10.1093/hmg/ddg182
© 2003 Oxford University Press

Dimerization of SOX9 is required for chondrogenesis, but not for sex determination

Pascal Bernard1,{dagger}, Paisu Tang2,{dagger}, Siyuan Liu1, Phoebe Dewing1, Vincent R. Harley2 and Eric Vilain1,*

1UCLA Departments of Human Genetics, Pediatrics and Urology, Gonda Center, Room 6357, 695 Charles Young Drive South, Los Angeles, CA 90095-7088, USA and 2Human Molecular Genetics Laboratory, Prince Henry's Institute of Medical Research, Monash Medical Centre, 246 Clayton Road, Melbourne, Victoria 3168, Australia

Received January 13, 2003; Revised March 31, 2003; Accepted May 14, 2003

The SRY-related SOX9 gene is involved in both chondrogenesis and the early steps of mammalian sex determination. Mutations in the human SOX9 gene cause campomelic dysplasia, a severe skeletal malformation syndrome associated with male-to-female sex reversal in most, but not all, XY individuals. Here we show that SOX9 contains a dimerization domain, and binds co-operatively as a dimer in the presence of the DNA enhancer element in genes involved in chondrocyte differentiation, such as Col11a2 and Col9a2, but binds as a monomer to the regulatory region of the sex-determining gene SF1. Frameshift SOX9 mutations truncate its two activation domains, while all missense mutations reported to date lie in the high mobility group (HMG) DNA-binding domain. We identify a missense mutation (A76E), the first outside the HMG domain, in an XY patient presenting with campomelic dysplasia but without sex reversal. This mutation disrupts the dimerization capability of SOX9, interfering with both the DNA binding and consequent transactivation of both the Col11a2 and Col9a2 enhancers. Consistent with the patient's phenotype, the A76E mutation does not affect DNA binding and activation of the SF1 enhancer. DNA-dependent cooperative dimerization could represent a novel mechanism to achieve tissue-specific regulation of gene expression by a SOX transcription factor. These results establish that SOX9 cooperative dimerization is required for chondrogenesis but not for sex determination and may explain why campomelic dysplasia need not be associated with XY sex reversal.

* To whom correspondence should be addressed. Tel: +1 3102672455; Fax: +1 3107945446; Email: evilain{at}ucla.edu

{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
T. Hattori, F. Coustry, S. Stephens, H. Eberspaecher, M. Takigawa, H. Yasuda, and B. de Crombrugghe
Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5
Nucleic Acids Res., May 1, 2008; 36(9): 3011 - 3024.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Guimont, F. Grondin, and C. M. Dubois
Sox9-dependent transcriptional regulation of the proprotein convertase furin
Am J Physiol Cell Physiol, July 1, 2007; 293(1): C172 - C183.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. C. Lynn, S. B. Smith, M. E. Wilson, K. Y. Yang, N. Nekrep, and M. S. German
Sox9 coordinates a transcriptional network in pancreatic progenitor cells
PNAS, June 19, 2007; 104(25): 10500 - 10505.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Sumi, N. Iehara, H. Akiyama, T. Matsubara, A. Mima, H. Kanamori, A. Fukatsu, D. J. Salant, T. Kita, H. Arai, et al.
SRY-Related HMG Box 9 Regulates the Expression of Col4a2 through Transactivating Its Enhancer Element in Mesangial Cells
Am. J. Pathol., June 1, 2007; 170(6): 1854 - 1864.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Wilhelm, R. Hiramatsu, H. Mizusaki, L. Widjaja, A. N. Combes, Y. Kanai, and P. Koopman
SOX9 Regulates Prostaglandin D Synthase Gene Transcription in Vivo to Ensure Testis Development
J. Biol. Chem., April 6, 2007; 282(14): 10553 - 10560.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. A. Genzer and L. C. Bridgewater
A Col9a1 enhancer element activated by two interdependent SOX9 dimers
Nucleic Acids Res., February 28, 2007; 35(4): 1178 - 1186.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Kou and S. Ikegawa
SOX9-dependent and -independent Transcriptional Regulation of Human Cartilage Link Protein
J. Biol. Chem., December 3, 2004; 279(49): 50942 - 50948.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
B. Moniot, S. Biau, S. Faure, C. M. Nielsen, P. Berta, D. J. Roberts, and P. de Santa Barbara
SOX9 specifies the pyloric sphincter epithelium through mesenchymal-epithelial signals
Development, August 1, 2004; 131(15): 3795 - 3804.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
V. R. Harley, M. J. Clarkson, and A. Argentaro
The Molecular Action and Regulation of the Testis-Determining Factors, SRY (Sex-Determining Region on the Y Chromosome) and SOX9 [SRY-Related High-Mobility Group (HMG) Box 9]
Endocr. Rev., August 1, 2003; 24(4): 466 - 487.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.